Pharmaceuticals 2010, 3(8), 2398-2415; https://doi.org/10.3390/ph3082398
Combinations of drugs in the Treatment of Obesity
1
Obesity & Metabolic Syndrome Group, Discipline of Endocrinology & Metabolism, Hospital das Clínicas, Faculty of Medicine, University of São Paulo, Av. Dr. Enéas de Carvalho Aguiar, 255, 7º andar, sala 7037, 05403-000 - São Paulo, SP, Brazil
2
Laboratory of Carbohydrates and Radioimuneassay/LIM-18, Faculty of Medicine, University of São Paulo, Av. Dr Arnaldo, 455 01246-903 - São Paulo, SP, Brazil
*
Author to whom correspondence should be addressed.
Received: 8 June 2010 / Revised: 9 July 2010 / Accepted: 15 July 2010 / Published: 27 July 2010
(This article belongs to the Special Issue Anti-Obesity Drugs)
Abstract
Obesity is a chronic disease associated with excess morbidity and mortality. Clinical treatment, however, currently offers disappointing results, with very high rates of weight loss failure or weight regain cycles, and only two drugs (orlistat and sibutramine) approved for long-term use. Drugs combinations can be an option for its treatment but, although widely used in clinical practice, very few data are available in literature for its validation. Our review focuses on the rationale for their use, with advantages and disadvantages; on combinations often used, with or without studies; and on new perspectives of combinations being studied mainly by the pharmaceutical industry. View Full-TextKeywords:
drug combination; phentermine; fenfluramine; ephedrine; caffeine; sibutramine; orlistat; metformin; bupropion; naltrexone; zonisamide; topiramate; pramlintide; metreleptin; leptin; glucagon-like peptide-1; peptide YY; 5-hydroxytryptophan; carbidopa; noradrenergic drugs; antidepressants
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).
Share & Cite This Article
MDPI and ACS Style
Halpern, B.; Oliveira, E.S.L.; Faria, A.M.; Halpern, A.; Melo, M.E.; Cercato, C.; Mancini, M.C. Combinations of drugs in the Treatment of Obesity. Pharmaceuticals 2010, 3, 2398-2415.
Related Articles
Article Metrics
Comments
[Return to top]
Pharmaceuticals
EISSN 1424-8247
Published by MDPI AG, Basel, Switzerland
RSS
E-Mail Table of Contents Alert